The shaping and functional consequences of the microRNA landscape in breast cancer.
about
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialThe path to routine use of genomic biomarkers in the cancer clinicGenome-wide analysis of microRNA and mRNA expression signatures in cancerMicroRNAs and Growth Factors: An Alliance Propelling Tumor ProgressionImaging tumour heterogeneity of the consequences of a PKCα-substrate interaction in breast cancer patientsMicroRNAs and triple negative breast cancerExcess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivoExploring circulating micro-RNA in the neoadjuvant treatment of breast cancerIndividual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumorsIdentification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastomaThe miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancerA Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer CompoundsA Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome.Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they controlmiRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancerAssociation of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary reportThe miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland.Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion.Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan.Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology.Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients.MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma.Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.MicroRNA profile in very young women with breast cancerThe microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cellsmicroRNA133a targets Foxl2 and promotes differentiation of C2C12 into myogenic progenitor cells.Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 statusLoss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.Rescuing dicer defects via inhibition of an anti-dicing nuclease.High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.A microRNA signature associated with early recurrence in breast cancer.Epigenetic and transcriptional determinants of the human breastInvolvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.The CDX1-microRNA-215 axis regulates colorectal cancer stem cell differentiationIntegrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancerMicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescenceCirculating miR-200c and miR-141 and outcomes in patients with breast cancer.
P2860
Q26782613-2FFB2144-9E4E-4062-91AF-A79BF14C6245Q26782733-96B4A22C-93AD-4151-9309-9FC70FB21A26Q26795603-27EDD3FE-2B8C-4E7C-AA14-B139598396D5Q26796592-DE56EBC6-3ADF-44E5-967A-0E89A89FFEA6Q26858812-E61CFB7E-4DA8-4C89-A28E-CC2B2A8A8465Q26862716-9C0069D0-9F14-4291-AAF9-29C871072DD4Q27332302-6E37F406-BE0D-475A-8190-06B70FFB0656Q28066481-4EE0229A-7DA2-4065-95D3-47B5B699D425Q28302352-2EB9CF68-A8B1-437D-B926-4D708C93F875Q28397795-A4AC9934-7D49-4F2B-8805-DC335BD13A95Q28468629-ABFEE8A3-71FA-4773-BD68-F3894A8369CAQ28598343-A5194A76-5ABF-40A6-97CC-853503B33759Q30488426-6A359E43-62F8-4541-AB9E-3463E49BF554Q30577477-5DA12CB7-7104-4CCC-B2FD-8E417B1F3D8EQ31136911-70BA5BD0-9F8B-4E53-8F70-8DB19158627AQ33571906-E537E1E9-381D-4D95-990D-402A5D79FD8FQ33579853-DE1EBA77-B2D0-4820-9900-F5339884C718Q33588077-5A793852-039E-4E8F-A7D9-0EC41247FAEFQ33682041-DF1D1165-0CFC-4FEE-9A5E-787BE1251649Q33741864-5602BFB1-3669-418B-9D0D-BE559A2775B1Q33773806-9B043903-465A-4A3E-93EC-2BDA9DE77FD8Q33846279-C9B1CE6E-B457-40EE-81DB-ED03F7C5C562Q34088205-64ACD7DB-DFDD-42DA-86E8-E2BDE8C8CEA0Q34259271-F1BF672C-20EB-4375-B356-6C0AF2AA86CCQ34267035-90FD4A73-607F-4F70-99C6-D6447D9F0A1FQ34468715-DCED30A8-97E0-44A3-9825-4AE2496D0229Q34592870-D6986678-841C-4928-8D38-5A1AE6AE6830Q34802552-07519D35-FE9C-4533-B8E5-49E16565DEDDQ34882515-96C43467-4F08-42DE-9FE2-DF72C363C7FDQ34979662-8C6ECD7F-FA64-4803-8451-A3005E223FC6Q35002243-CADDD354-2FCB-4BC3-9BA6-6BD28FAB2385Q35024073-C6F3AADE-C33E-46DA-97FA-472B0B9C900FQ35094742-AC660B9F-3CF4-4B2C-A8A6-B1AAACDB8F30Q35121814-290C688B-B785-4B92-9C27-0C2DDB37C9B7Q35138074-81FF58E1-57D5-4FD1-B4C7-C2A5F9E9026DQ35164353-A2768CA7-3559-41DF-AA9C-81286462846EQ35280248-3859EF8A-F311-4128-BBB9-E03C5AFF2B33Q35410361-A142139D-B902-4C43-8CCF-16D2249A8863Q35451400-053A9A15-EC70-4EDE-9228-271B1E5DF669Q35518887-74A36CC2-24DF-4A36-9C36-988540C7B021
P2860
The shaping and functional consequences of the microRNA landscape in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The shaping and functional consequences of the microRNA landscape in breast cancer.
@en
The shaping and functional consequences of the microRNA landscape in breast cancer.
@nl
type
label
The shaping and functional consequences of the microRNA landscape in breast cancer.
@en
The shaping and functional consequences of the microRNA landscape in breast cancer.
@nl
prefLabel
The shaping and functional consequences of the microRNA landscape in breast cancer.
@en
The shaping and functional consequences of the microRNA landscape in breast cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
The shaping and functional consequences of the microRNA landscape in breast cancer.
@en
P2093
Andrea Sottoriva
Elena Provenzano
Gulisa Turashvili
Javier Armisen
Martin Hirst
Sam Aparicio
Yongjun Zhao
P2860
P2888
P304
P356
10.1038/NATURE12108
P407
P50
P577
2013-05-05T00:00:00Z
P5875
P6179
1027957670